SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul S. who wrote (497)4/29/1998 2:48:00 PM
From: Saracen  Read Replies (1) of 1185
 
From my limited knowledge of the requirements for a NASDAQ small cap listing, I would guess that Nortran does meet all of these except for the share price (need US$4 for initial listing?). However, I believe that management's priority at this time is the T.S.E. listing, which is a great stepping stone towards ultimately listing in the U.S.

Here is the latest rumor that I just heard this morning:

There is a Nortran directors' meeting in the next few days to approve the deal with whomever is the major drug company. Remember - this is simply a rumor, and so should be taken with a grain of salt.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News